Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The transformative impact of extracellular vesicles on developing sperm. | Reprod Fertil | 2021 | 35118397 | PubTator, text mining | PubMed |
Enzyme Responsive Vaginal Microbicide Gels Containing Maraviroc and Tenofovir Microspheres Designed for Acid Phosphatase-Triggered Release for Pre-Exposure Prophylaxis of HIV-1: A Comparative Analysis of a Bigel and Thermosensitive Gel. | Gels | 2021 | 35049550 | PubTator, text mining | PubMed |
| Prostate Cancer: Early Detection and Assessing Clinical Risk Using Deep Machine Learning of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data. | Front Immunol | 2021 | 34975879 | PubTator, text mining | PubMed |
| On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances. | Int J Mol Sci | 2021 | 34948334 | PubTator, text mining | PubMed |
| What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy. | J Pers Med | 2021 | 34945784 | PubTator, text mining | PubMed |
| ATMP Environmental Exposure Assessment in European Healthcare Settings: A Systematic Review of the Literature. | Front Med (Lausanne) | 2021 | 34926483 | PubTator, text mining | PubMed |
| Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union. | Front Pharmacol | 2021 | 34916948 | PubTator, text mining | PubMed |
| Somatic mutations and CRISPR/Cas9 library screening integrated analysis identifies cervical cancer drug-resistant pathways. | Clin Transl Med | 2021 | 34911161 | PubTator, text mining | PubMed |
| Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma. | Front Pharmacol | 2021 | 34899292 | PubTator, text mining | PubMed |
| Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases. | Diagn Pathol | 2021 | 34895266 | PubTator, text mining | PubMed |
| Vaccine-Based Immunotherapy for Head and Neck Cancers. | Cancers (Basel) | 2021 | 34885150 | PubTator, text mining | PubMed |
| Protein Tyrosine Phosphatases: Mechanisms in Cancer. | Int J Mol Sci | 2021 | 34884670 | PubTator, text mining | PubMed |
| Delineating the Molecular Events Underlying Development of Prostate Cancer Variants with Neuroendocrine/Small Cell Carcinoma Characteristics. | Int J Mol Sci | 2021 | 34884545 | PubTator, text mining | PubMed |
| Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine. | Mol Cancer | 2021 | 34872584 | PubTator, text mining | PubMed |
| LTF Regulates the Immune Microenvironment of Prostate Cancer Through JAK/STAT3 Pathway. | Front Oncol | 2021 | 34868909 | PubTator, text mining | PubMed |
| A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy. | Front Oncol | 2021 | 34868907 | PubTator, text mining | PubMed |
| Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment. | Vaccines (Basel) | 2021 | 34835229 | PubTator, text mining | PubMed |
| Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose? | Int J Mol Sci | 2021 | 34830449 | PubTator, text mining | PubMed |
| Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect. | Int J Mol Sci | 2021 | 34830221 | PubTator, text mining | PubMed |
| Prostate Cancer Presenting With an Unusual Presentation of Rectal Pain and Bleeding. | Cureus | 2021 | 34804647 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=22